What is considered hyperlipidemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Considered Hyperlipidemia?

Hyperlipidemia is defined as elevated fasting serum lipid levels, with triglyceride levels ≥150 mg/dL or LDL cholesterol levels exceeding target thresholds based on cardiovascular risk. 1

Triglyceride Classification

According to the Endocrine Society guidelines, hypertriglyceridemia is categorized as:

  • Mild: 150-199 mg/dL (1.7-2.3 mmol/L)
  • Moderate: 200-999 mg/dL (2.3-11.3 mmol/L)
  • Severe: 1,000-1,999 mg/dL (11.3-22.6 mmol/L)
  • Very severe: ≥2,000 mg/dL (≥22.6 mmol/L) 1

Mild to moderate hypertriglyceridemia increases cardiovascular disease risk, while severe and very severe levels significantly raise the risk of acute pancreatitis.

LDL Cholesterol Targets

LDL cholesterol targets vary based on cardiovascular risk:

  • Very high-risk patients: <1.8 mmol/L (<70 mg/dL) or ≥50% reduction if target cannot be reached
  • High-risk patients: <2.5 mmol/L (<100 mg/dL)
  • Moderate-risk patients: <3.0 mmol/L (<115 mg/dL) 1

Metabolic Syndrome Criteria

Hyperlipidemia is a key component of metabolic syndrome, which is diagnosed when a person has 3 or more of these risk factors:

  • Increased waist circumference (≥40 inches in men, ≥35 inches in women)
  • High triglycerides (≥150 mg/dL) or taking medication for high triglycerides
  • Low HDL-C (<40 mg/dL in men, <50 mg/dL in women) or taking medication for low HDL-C
  • Elevated blood pressure (≥130/85 mm Hg) or taking antihypertensive medication
  • Elevated fasting glucose (≥100 mg/dL) or taking medication to control blood sugar 1

Primary vs. Secondary Hyperlipidemia

Primary Causes

Primary hyperlipidemia includes genetic disorders such as:

  • Familial hypertriglyceridemia
  • Familial combined hyperlipidemia
  • Familial dysbetalipoproteinemia 1

Familial hypercholesterolemia is characterized by total cholesterol >8 mmol/L (320 mg/dL) and LDL cholesterol >6 mmol/L (240 mg/dL). 1

Secondary Causes

Secondary causes of hyperlipidemia include:

  • Lifestyle factors: Excessive alcohol intake, physical inactivity, diet rich in simple carbohydrates
  • Medical conditions: Untreated diabetes, hypothyroidism, obesity, metabolic syndrome, renal or liver disease, pregnancy, autoimmune disorders
  • Medications: Thiazides, beta blockers, estrogen, isotretinoin, corticosteroids, bile acid-binding resins, antiretroviral protease inhibitors, immunosuppressants, antipsychotics 1, 2

Clinical Implications

  1. Cardiovascular Risk: Elevated triglycerides and LDL cholesterol increase the risk of atherosclerosis and cardiovascular disease 3

  2. Pancreatitis Risk: Severe hypertriglyceridemia (>1,000 mg/dL) significantly increases the risk of acute pancreatitis 1, 4

  3. Non-HDL Cholesterol: For patients with hypertriglyceridemia, non-HDL cholesterol (calculated by subtracting HDL from total cholesterol) is a better predictor of cardiovascular risk than LDL cholesterol alone 1

Common Pitfalls in Diagnosis

  1. Fasting Status: Lipid levels should be measured after a 12-hour fast for accurate triglyceride assessment 1

  2. Secondary Causes: Always evaluate for secondary causes of hyperlipidemia before initiating treatment 1

  3. Risk Assessment: Don't rely solely on lipid levels; assess overall cardiovascular risk using multiple factors 1

  4. Small LDL Particles: In patients with diabetes or metabolic syndrome, small dense LDL particles may be atherogenic even at normal LDL-C concentrations 1

  5. Non-Fasting Samples: When triglycerides are elevated, calculated LDL may be inaccurate; consider using non-HDL cholesterol instead 1

By identifying and properly classifying hyperlipidemia, clinicians can implement appropriate treatment strategies to reduce cardiovascular risk and prevent complications like pancreatitis in patients with severe hypertriglyceridemia.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Secondary causes of hyperlipidemia.

The Medical clinics of North America, 1994

Research

Epidemiology and management of hyperlipidemia.

The American journal of managed care, 2017

Research

Hypertriglyceridemia: its etiology, effects and treatment.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.